Delivery Order SPE2D020D0014-SPE2D325F9638

Award Date 4/11/25
Potential Completion Date 4/16/25
Potential Value $2.8K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10001, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc., a large pharmaceutical manufacturer, for the supply of Naloxone 4 mg/10 ml vials. The contract has a ceiling value of $2,820.00 and is a firm fixed price, delivery order contract type with a performance period ending on February 26, 2025. The contract does not utilize a small business set-aside designation. Pfizer is the prime contractor for this award, which is part of the...
This is a firm fixed-price delivery order awarded by the Medical Supply Chain, a defense agency, to Pfizer Inc., a large pharmaceutical manufacturer, for the supply of 4568256080 NALOXONE 4 MG/10 ML VIAL 10ML. The contract has a ceiling value of $8,460.00 and a period of performance ending on May 20, 2025. The award date is May 15, 2025. This contract is not set-aside for small businesses. Pfizer is an established prime contractor that holds significant federal contract vehicles, including a...
This federal contract award was issued by the Defense Logistics Agency Troop Support Medical, a defense agency, to Pfizer Inc., a global pharmaceutical corporation. The contract is for the delivery of Naloxone 0.4 mg/ml vials, a critical medication used to reverse opioid overdoses. The contract has a firm fixed price of $1,809.60 and a completion date of December 16, 2024. The contract was awarded without a set-aside designation, reflecting Pfizer's status as a large corporation. As a major...
This is a federal delivery order contract awarded by the Medical Supply Chain, a component of the Defense Logistics Agency Troop Support, to Pfizer Inc. The contract is for the supply of 4 mg/10 ml vials of the opioid overdose reversal drug Naloxone, with a ceiling value of $2,820. The contract is a firm-fixed price arrangement with a period of performance extending through February 27, 2025. This contract is not designated as a small business set-aside. Pfizer is a large, for-profit...
This federal contract award to Pfizer Inc., valued at $8,460.00, is for the delivery of 4,566,739 vials of 4 mg/10 ml naloxone, an opioid overdose reversal medication. The contract was awarded by the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense, without any set-aside designations. Pfizer, a large pharmaceutical manufacturer, is the prime contractor on this delivery order. The contract has an ultimate completion date of December 20, 2024. Pfizer also...
The U.S. Defense Logistics Agency (DLA) awarded a $2,820.00 firm-fixed-price delivery order contract to Pfizer Inc. for the supply of 4 mg/10 mL vials of the opioid overdose reversal medication Naloxone. This contract has an ultimate completion date of April 2, 2025 and does not utilize a small business set-aside. Pfizer, a large pharmaceutical manufacturer, has extensive experience providing critical medical supplies to federal agencies, including the Department of Veterans Affairs, Centers for...
This is a $5,640.00 firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc., a global pharmaceutical corporation. The contract is for the delivery of 4,567,312,684 units of 4 mg/10 mL vials of the opioid overdose reversal drug Naloxone. The contract has a period of performance ending on February 24, 2025. This award is not associated with a set-aside program. Pfizer is the prime contractor and no subcontractors are mentioned. The Defense...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,096 units of Naloxone 2 mg/2 ml syringes, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $1,420.33 and a period of performance through January 31, 2025. This delivery order is part of a larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,210.86, is for the procurement of 4566845391 - NALOXONE 0.4 MG/ML VIALML. The contract has a completion date of January 7, 2025 and is a Firm Fixed Price contract. This order is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,915,829 units of Naloxone 2 mg/2 mL syringes. The contract has a firm fixed price of $1,888.60 and a performance period ending on January 14, 2025. It is not designated as a set-aside contract. The contract is awarded under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
  • SPE2D020D0014
    Indefinite Delivery Contract
  • SPE2D020D0014-SPE2D325F9638
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc., a large pharmaceutical manufacturer, for the supply of Naloxone 4 mg/10 ml vials. The contract has a ceiling value of $2,820.00 and is a firm fixed-price contract. The ultimate completion date is April 16, 2025. This contract does not utilize a small business set-aside. Pfizer is a significant prime contractor for the federal government, holding several Indefinite Delivery Vehicle (IDV) contracts, including a $46,893,140 contract for Bevacizumab injections and a $2,007,801,000 contract for the Vaccines for Children (VFC) program with the Centers for Disease Control and Prevention. These IDV contracts demonstrate Pfizer's extensive capabilities in supplying complex pharmaceutical products across diverse government healthcare programs.

Generated 7/11/25, 9:57 AM